Glass House Brands Inc (NYSE: GLAS) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $146M. The Maz Rating grades it against the other companies in its sector.
Glass House Brands Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $1.66, Glass House Brands Inc trades at 0.9x sales and 1.8x book value. Over the last twelve months it generated about $165M of revenue and a net loss of $57M. It runs a gross margin of 33.1%, an operating margin of -24.4% and a net margin of -31.0%. It shows return on equity of -50.9%, return on invested capital of -14.4% and a free cash flow yield of -25.3%. On the balance sheet: a debt-to-equity ratio of 1.00 and a current ratio of 1.33. Over the past 52 weeks the share price ranged from $1.07 to $13.19, with a beta of 0.51.
Glass House Brands Inc does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.